活性跟踪法研究地骨皮中抑制NF—κB的化学成分(4)
[5] Ghosh S,Hayden M S. New regulators of NF-κB in inflammation [J]. Nat Rev Immunol,2008,8(11): 837.[6] Rial N S,Choi K,Nguyen T,et al. Nuclear factor kappa B(NF-κB): a novel cause for diabetes,coronary artery disease and cancer initiation and promotion[J]. Med Hypotheses,2012,78(1): 29.
[7] 郭宗儒. 药物分子设计的策略: 双靶标药物设计 [J].药学学报 ......
您现在查看是摘要页,全文长 2764 字符。